Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Roche to further reduce Genentech stake

According to DNA, Roche has filed with the SEC to sell

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE